Celtic Renewables (CR) converts residual by-products from Scottish Whisky production into high-value, low-carbon sustainable chemical and biofuel products using its patented Acetone-Butanol-Ethanol (ABE) fermentation process. CR asserts that the end products, Acetone, Butanol, Ethanol & high-grade animal feed, play an important role in daily human lives. The company argues that these are potential applicants in industries such as pharmaceuticals, cosmetics, food production, hygiene products & advanced sustainable biofuels. CR states that the downstream markets for ABE biochemicals would be worth over £130 billion by 2025. It aims to be a leading contender in this segment. It also endeavours to replicate its ABE technology in global markets. CR has been named the 'Most Innovative Biotech SME' in Europe. The company will use the investment to bring its first industrial-scale plant into full operation by Q1 of 2021 and capitalise on commercial opportunities.
days to go:
Expired
investment:
£3,576,901
Crover intends to leverage the world's first proprietary method for locomotion in bulk solids. It argues that globally, 20% (60% in developing areas) of harvested grains are wasted during storage that led to almost 631 million tonnes of grains being wasted in 2018. Crover claims CROVER, its robotic grain monitoring device, can fluently “swim” in stored grains, monitor their conditions, reduce losses due to spoilage and avoid a drop in quality of these valuable crops. The company argues CROVER can provide hi-resolution readings across the storage unit and help hinder pest growth, allowing for early detection of potential spoilage. Crover was awarded £614,000 in grant funding including, £212,000 from Innovate UK. It has featured in publications such as The Times, Farmers Weekly, and Milling & Grain. They intend to use the investment to begin arranging and readying parties regarding new pilot programmes and begin small series manufacturing for these pilot schemes.
days to go:
Expired
investment:
£337,762
GIBIE combines ancient Indian dying methods with modern weaving technologies to produce sustainable and luxurious homewares. The company argues that the textile industry uses an astonishing 9 trillion gallons of water annually, as well as, releases harmful gases and chemicals in the air and water. GIBIE aims to change this scenario by bringing forth sustainable linen that has superior qualities to chemically enhanced and dyed linen. It has come out with an industrial-scale production proposal of its linen. The company is a PETA-approved vegan brand and a member of the Color Ashram Foundation that promotes the usage of herbal dyes around the world. GIBIE will use the investment to launch its essential sales programs, boost marketing initiatives and scale production.
days to go:
Expired
investment:
£158,571
Brickowner aims to become the leading service provider for property developers and asset managers, ensuring benefits for both parties. The company undertakes background checks of investors on its portal for the benefit of asset managers. It also ensures that investors can easily navigate its portal and find deals that suit their financial appetite. Brickowner successfully exited five investment rounds despite two investments happening in the wake of COVID-19. The platform has over 3,000 investors registered with over 700 active investors. It has overseen £14 million worth of investment on its portal to date. Brickowner will use the investment towards technology up-gradation, hire strategic personnel to expand marketing, and increase its marketing spend.
days to go:
Expired
investment:
£132,528
Nova is a world-leading and award-winning tidal energy company. It designs, builds, and operates tidal turbines that generate electricity from the flow of the tide and the natural ebb. Nova's underwater turbines work in harmony with marine environment and have zero visual impact. In 2018, Nova received international recognition at the G7 summit and won ‘Outstanding Project’ at the Green Energy Awards the same year. Nova aims to become cost-competitive with traditional baseload fossil fuels. With the proceeds, the company will fulfil its purpose of Business Growth (25%), Project Delivery (50%), and Commercial Readiness (25%).
days to go:
Expired
investment:
£1,255,666
Brickowner aims to become the leading service provider for property developers and asset managers, ensuring benefits for both parties. The company asserts that it undertakes background checks of investors on its portal for the benefit of asset managers. It also ensures that investors can easily navigate its portal and find deals that suit their financial appetite. Brickowner successfully exited five investment rounds despite two investments happening in the wake of COVID-19. The platform has over 3,000 investors registered with over 700 active investors. It has overseen over £15 million worth of investments on its portal till date. Brickowner will use the investment towards technology up-gradation, develop its B2B capacity, and increase marketing initiatives to support company growth
days to go:
Expired
investment:
£290,362
Nooro makes cannabidiol (CBD) snack bars. Company founder J.D. Furlong asserts that blending CBD and certain nootropics lead to better cognitive functions in individuals. Nooro also argues that it is the UK's first CBD snack bar seller that is plant-based and gluten-free. The company's products are stocked across 250 retail outlets, cafes, gyms, and delis across the UK. Nooro pivoted to Direct-to-Consumer (D2C) sales during COVID-19 to get better margins. It invested in creating a business model with four distinct revenue streams with 60% earnings coming via e-commerce D2C sales, 15% via digital affiliate sales, 15% via direct sales to partners, and 10% via wholesalers. The company will use the investment to launch an additional three new flavours by February 2021 and grow its business across different verticals.
days to go:
Expired
investment:
£235,819
Marine Power Systems (MPS) states that it has developed a technology that can harness wind power, wave power or combined wind and wave energy at grid scale. It argues that governments worldwide are looking for alternative sources to meet global energy consumption needs. MPS endeavours to usher in an energy revolution and become a contender in the floating offshore energy market that is set to be worth over $100 billion by 2035. MPS claims to have successfully tested its medium-scaled prototype in the ocean, demonstrating the ease of transportation, deployment, and showcasing the devices ability to generate grid compliant electricity. The company has been awarded a £12.8 million grant by the European Union (EU) to deliver a full scale, grid-connected commercial demonstrator in 2022. It says it will use the investment to conduct its final phase of development and testing before taking its devices to market in Q1 of 2024.
days to go:
Expired
investment:
£4,151,001
Small Beer Brewing Company specialises in brewing classic beer with an Alcohol By Volume (ABV) below 2.8% without any loss in flavour. The company asserts that the beer market is worth £18.4 billion in the UK and over £520 billion globally. In the UK, the 'Low & No' category sits at £450 million. The company aims to be a major contender in this category. It is already exporting its products to Iceland, Singapore, Hong Kong & Spain. The company's stockists include entities like Majestic Wine, Ocado and Waitrose. It will use the investment to fund its expansion both in the UK & foreign markets.
days to go:
Expired
investment:
£750,004
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
